HOW DID WE GET HERE? THE SCOUT PLATFORM
With clinically insignificant MRI artifact, there is no restriction on the imaging modalities that can be used effectively throughout a patient’s treatment. This gives physicians the ability to place a reflector at the time of biopsy, prior to neoadjuvant chemotherapy (NAC), and to enable targeted axillary dissection. While SCOUT has been used primarily for breast tumor localization, physicians are recognizing the clinical benefits, including 1+/- mm accuracy, 60-mm depth, and 360° detection, are applicable for myriad oncological applications, including nodes, sarcoma, and lung.